AVENUE THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $3.5M | $3.8M |
| FY2022 | — | $3.9M | $6.7M |
| FY2023 | — | $1.6M | $1.8M |
| FY2024 | — | $2.8M | $2.6M |
| FY2025 | — | $1.8M | $2.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $3.5M | $3.8M |
| FY2022 | — | $3.9M | $6.7M |
| FY2023 | — | $1.6M | $1.8M |
| FY2024 | — | $2.8M | $2.6M |
| FY2025 | — | $1.8M | $2.9M |